Welcome to our dedicated page for Walgreen Boots news (Ticker: WBA), a resource for investors and traders seeking the latest updates and insights on Walgreen Boots stock.
This page provides a focused view of news and announcements historically associated with Walgreens Boots Alliance, Inc. (formerly Nasdaq: WBA) and its related businesses, including Walgreens and Walgreens Specialty Pharmacy. Company communications highlight Walgreens as a U.S. retail pharmacy brand founded in 1901 that serves nearly 9 million customers and patients each day across approximately 8,500 stores in the U.S. and Puerto Rico, and Walgreens Boots Alliance as a pharmacy-led health and wellbeing enterprise formed through the combination of Walgreens and Alliance Boots.
News related to WBA and Walgreens has covered several key themes. One major area is corporate transactions and capital markets activity. In 2025, a series of announcements detailed the Agreement and Plan of Merger under which Blazing Star Merger Sub, Inc. merged with and into Walgreens Boots Alliance, Inc., resulting in the company becoming a wholly owned subsidiary of Blazing Star Parent, LLC, an affiliate of Sycamore Partners. Related releases described tender offers and consent solicitations for various series of Walgreens Boots Alliance and Walgreen Co. notes, pricing terms, extensions of expiration times and settlement dates, and the final results of these offers.
Another important news category involves the company’s transition from public to private ownership. A Form 8-K filed on August 28, 2025 describes the completion of the merger, the cash consideration and divested asset proceed rights received by shareholders, and the cessation of trading of WBA common stock and certain notes on Nasdaq. A subsequent Form 25 documents the removal of these securities from listing, and a Form 15 filed on September 8, 2025 terminates registration and suspends reporting obligations. Sycamore Partners separately announced the completion of its acquisition of Walgreens Boots Alliance, Inc. and its intention that Walgreens, The Boots Group, Shields Health Solutions, CareCentrix and VillageMD operate as standalone companies under private ownership.
Operational and healthcare-focused news also features prominently. Walgreens Specialty Pharmacy announced an expansion of its limited distribution drug network to 265 products, emphasizing its role in specialty medications for patients with rare, complex and chronic diseases and its independence from pharmacy benefit managers. Walgreens has also issued releases on vaccination services, including nationwide flu shot availability for individuals three years and older, walk-in and scheduled appointments, digital check-in features and incentives for myWalgreens members receiving vaccines.
Investors and observers using this news page can review historical coverage of WBA’s merger process, debt tender offers, governance and shareholder actions, as well as Walgreens’ specialty pharmacy initiatives and vaccination programs. For those tracking the evolution of the company, these articles collectively document WBA’s path from a publicly traded integrated healthcare and retail group to a privately held organization under Sycamore Partners, while also illustrating how Walgreens positions its pharmacies and specialty operations within the broader healthcare landscape.
Walgreens Boots Alliance (WBA) will announce its fourth quarter and fiscal 2021 earnings results on Thursday, Oct. 14, 2021, at 7 a.m. Eastern time, along with supplementary financial slides. Following this, a Virtual Investor Conference will be held at 8:30 a.m. Eastern time, led by WBA’s global leadership team, discussing future strategic priorities and initial outlook for fiscal 2022. Investors can access a live simulcast and presentation materials on WBA’s investor relations website.
Blue Shield of California and Walgreens announced a collaboration to improve healthcare access for Californians, focusing on cost reduction and innovative consumer services. The initiative will debut Walgreens Health Corner™ services, enhancing care through health advisors like pharmacists and dieticians. Initially, eligible Blue Shield members will access services such as blood pressure screenings and A1C blood tests. The program aims to expand further in 2022, promoting holistic health solutions. This partnership supports Blue Shield's 'Health Reimagined' strategy to enhance care quality across communities.
Walgreens is expanding its mobile clinic initiative to provide COVID-19 and flu vaccinations at historically Black colleges and universities (HBCUs) across the nation. This initiative, responding to the surge of the delta variant, aims to enhance accessibility in underserved areas. The mobile clinic will visit over a dozen locations, including prominent football games, helping to tackle vaccination hesitancy. Walgreens has already set up approximately 1,300 off-site vaccination clinics nationwide, collaborating with local organizations to improve healthcare access.
Walgreens Boots Alliance (WBA) and VillageMD have announced plans to open 600 primary care clinics across over 30 U.S. markets within the next four years. The partnership aims to enhance healthcare delivery by integrating primary care services at Walgreens locations. Recently, they launched 18 Village Medical clinics in the Phoenix area, with four more expected by year-end. This initiative will create over 800 jobs in Arizona and address chronic illnesses, improving access to comprehensive care by combining pharmacy services with in-person and telehealth options.
Walgreens has launched Scarlet, a bank account and debit card powered by Mastercard and issued by MetaBank, to enhance financial wellness for customers. Available at over 9,000 Walgreens locations and online, Scarlet offers 3% Walgreens Cash rewards on eligible purchases, alongside personal finance tools. Accountholders receive features like $10 statement credits for initial spending, free direct deposits, and extensive ATM access. This initiative represents Walgreens' ongoing commitment to improving financial services and customer engagement.
US WorldMeds announced that Walgreens will stock LUCEMYRA (lofexidine) tablets in pharmacies nationwide effective September 1, 2021. LUCEMYRA is the only FDA-approved non-opioid treatment for opioid withdrawal symptoms, requiring a prescription. Eligible patients with commercial insurance may pay $0, while uninsured patients may face costs of $300. The announcement comes amid rising overdose deaths, exceeding 93,000 in 2020, according to the National Center for Health Statistics.
Walgreens has announced an increase in the starting hourly wage for its team members to $15.00, effective in phases starting October and fully implemented by November 1, 2022. This move, anticipating an investment of $450 million over three years, is aimed at retaining talent and enhancing community health care services. Since the pandemic began, Walgreens has added 25,000 pharmacy staff and implemented digital resources to improve patient care.
Walgreens Boots Alliance (WBA) announced key executive appointments to bolster leadership. Danielle Gray was named Executive Vice President and Global Chief Legal Officer, bringing significant legal experience. Tracey Brown, appointed President of Retail Products and Chief Customer Officer, will enhance customer experience and digital transformation strategies. Jeff Gruener takes the role of Senior Vice President and Chief Financial Officer, focusing on financial strategies to drive growth. These changes reflect WBA's commitment to innovation in healthcare and retail.
Walgreens is now offering flu shots for individuals aged 3 and up at over 9,000 locations nationwide, aiming to combat influenza amid a resurgence in COVID-19 cases. The CDC anticipates an active flu season as schools and workplaces reopen. Customers can receive both flu and COVID-19 vaccines in a single visit. Walgreens is enhancing its vaccine scheduling and expanding eligibility. In conjunction with its flu vaccine campaign, Walgreens continues its 'Get a Shot. Give a Shot' initiative, donating to the UN Foundation for childhood vaccinations worldwide.
Walgreens (Nasdaq: WBA) launched the myWalgreens Credit Card program in partnership with Synchrony Bank (NYSE: SYF). This program includes two innovative credit cards that reward personalized health and wellness choices, providing rewards at over 9,000 Walgreens locations and online. Cardholders can earn up to 10% in Walgreens Cash rewards on eligible purchases. The cards feature a digital-led experience for easy applications and seamless integration with the Walgreens app. This initiative expands Walgreens' financial services, aiming to enhance customer loyalty through unique health-focused rewards.